U.S. federal trademark · Serial No. 98139183 · Reg. No. 7630086
Oncology and hematology new product commercialization service for drug companies, namely, providing launch strategy, marketing strategy, commercialization modeling for advertising or sales promotion, and market access consulting services with respect to pricing and reimbursement, guideline and formulary submission, pathway submission, and advocacy planning
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.